A
Andrew J. Norton
Researcher at St Bartholomew's Hospital
Publications - 52
Citations - 4651
Andrew J. Norton is an academic researcher from St Bartholomew's Hospital. The author has contributed to research in topics: Follicular lymphoma & Lymphoma. The author has an hindex of 26, co-authored 52 publications receiving 4501 citations. Previous affiliations of Andrew J. Norton include University of Göttingen & Queen Mary University of London.
Papers
More filters
Journal ArticleDOI
Classification of cutaneous lymphoma: a critical appraisal of recent proposals.
TL;DR: The merits of REAL classification and EORTC classification for cutaneous lymphoproliferative disease are examined and a brief account of less common or ambiguous lymphoma types is provided.
Journal ArticleDOI
Myositis, polyserositis with a large pericardial effusion and constrictive pericarditis as manifestations of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation and subsequent donor lymphocyte infusion
L Silberstein,Andrew Davies,S Kelsey,James M. Foran,C Murrell,D D'Cruz,Sarah Vinnicombe,Andrew J. Norton,Jamie Cavenagh +8 more
TL;DR: A man with Hodgkin's disease refractory to chemotherapy and radiotherapy who was transplanted from an HLA-identical brother who developed cGVHD characterised, in particular, by polymyositis, polyserositis with a large pericardial effusion and constrictivePericarditis, 1 month after donor lymphocyte infusion for relapsed disease.
Journal ArticleDOI
Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.
P. N. Mainwaring,David Cunningham,Walter M Gregory,Peter Hoskin,Barry W. Hancock,Andrew J. Norton,Ken MacLennan,Paul Smith,GV Hudson,David C. Linch +9 more
TL;DR: In conclusion, the PMitCEBO 8-week combination chemotherapy regimen offers high response rates, durable remissions, and acceptable toxicity in elderly patients with HGL.
Journal ArticleDOI
Immunocytoma: a retrospective analysis from St Bartholomew's Hospital-1972 to 1996.
Demetris Papamichael,Andrew J. Norton,James M. Foran,C. Mulatero,John D. Mathews,J. A. L. Amess,Mike Bradburn,T. A. Lister,A. Z. S. Rohatiner +8 more
TL;DR: The proposed World Health Organization reclassification of IMC to include lymphoplasmacytoid lymphoma (Kiel classification) as a variant of B-CLL/SLL is supported.
Journal ArticleDOI
Epstein-Barr virus in angioimmunoblastic T-cell lymphomas.
TL;DR: It is concluded that the presence of EBV is a consequence of the disease rather than the cause and in situ hybridization for cytomegalovirus and human herpes virus type‐6 was negative in all cases.